Teda Biological (08189) announced its interim results, with a profit attributable to shareholders of 10.2083 million yuan, marking a year-on-year turnaround to profitability.
Teda Biotechnology (08189) announced its interim results for the six months ending June 30, 2026, with a revenue of 296 million yuan, an increase of 30.75% year-on-year; profit attributable to owners of the company was 10.2083 million yuan, compared to a loss of 6.4264 million yuan in the same period last year; earnings per share were 0.048 yuan.
Teda Biomedical (08189) announced its interim results for the six months ending June 30, 2026. The group achieved a revenue of 296 million yuan, a year-on-year increase of 30.75%; profit attributable to owners of the company was 10.2083 million yuan, compared to a loss of 6.4264 million yuan in the same period last year; earnings per share were 0.048 yuan.
Related Articles
YIK WO INTL (08659) announced its interim results, reporting a loss of 8.599 million yuan during the period, a reversal from profit to loss compared to the same period last year.
SUPERROBOTICS (08176) announced its interim results, reporting a loss attributable to shareholders of HKD 3.4 million, a year-on-year decrease of 41.1%.
METASURFACE (08637) released its interim results, with a net profit attributable to shareholders of SGD 3.705 million, a decrease of 57.69% compared to the same period last year.
YIK WO INTL (08659) announced its interim results, reporting a loss of 8.599 million yuan during the period, a reversal from profit to loss compared to the same period last year.
SUPERROBOTICS (08176) announced its interim results, reporting a loss attributable to shareholders of HKD 3.4 million, a year-on-year decrease of 41.1%.
METASURFACE (08637) released its interim results, with a net profit attributable to shareholders of SGD 3.705 million, a decrease of 57.69% compared to the same period last year.
RECOMMEND
